Mª Dolores
Mª Dolores Girón González, Granada ES
Patent application number | Description | Published |
---|---|---|
20120129919 | POLYCATIONIC AMPHIPHILIC CYCLOOLIGOSACCHARIDES AND THE USE THEREOF AS MOLECULAR TRANSPORTERS - The present invention relates to a group of polycationic amphiphilic cyclooligosaccharides which, due to their molecular structure, may be used as molecular transporters to the interior of cells. Furthermore, the present invention also relates to the use of said compounds in the preparation of a medicament, to the use of this medicament for gene therapy and to a pharmaceutical composition that comprises one of said compounds. | 05-24-2012 |
Mª Dolores Ludevid MÚgica, Sant Just Desvern ES
Patent application number | Description | Published |
---|---|---|
20120020992 | Production of Biologically Active Proteins - A fusion protein that is expressed in a recombinant protein body-like assembly (RPBLA) in host eukaryotic cells and organisms is disclosed. More particularly, a biologically active polypeptide fused to a protein sequence that mediates the induction of RPBLA formation is expressed and accumulated in host cells after transformation with an appropriate vector. The eukaryotic host cell does not produce protein bodies in the absence of the fusion protein. Methods for preparing and using the RPBLAs and the fusion protein are also disclosed, as are nucleic acid molecules that encode the fusion proteins. | 01-26-2012 |
Mª Dolores Parellada Ferrer, Madrid ES
Patent application number | Description | Published |
---|---|---|
20120172550 | CATALYST FOR THE HYDROGENATION OF UNSATURATED COMPOUNDS - Homogeneous catalyst based on titanium compounds of the type (R | 07-05-2012 |
Mª Dolores Pino Pino, Jaen ES
Patent application number | Description | Published |
---|---|---|
20120308586 | COMPOSITION BASED ON EXTRA VIRGIN OLIVE OILS - This invention relates to a composition based on a mixture of different olive oils, preferably virgin and extra virgin olive oils, from ecological farms, and to the use thereof in the treatment or prevention of different disorders in humans and animals. Moreover, this invention also relates to a dermatological/dermocosmetic preparation that comprises the composition of this invention and to the use of this dermatological/dermocosmetic preparation in the treatment of skin disorders in humans and animals. Underlying these systemic and/or skin disorders, there are metabolic and immunoinflammatory-oxidative alterations, which may be positively modified by the systemic (oral) or topical (cutaneous) use of the composition of this invention. The special physical-chemical structure of the composition allows for a better digestive and cutaneous arrangement. | 12-06-2012 |